Vistagen Therapeutics (VTGN) Preferred Shares (2011 - 2021)
Vistagen Therapeutics (VTGN) posted Preferred Shares of $2300.0 for Q3 2021, up 360.0% sequentially from $500.0 in Q2 2021, and up 91.67% YoY from $1200.0 in Q3 2020.
Vistagen Therapeutics (VTGN) Preferred Shares (2011 - 2021) Analysis & Trends
Vistagen Therapeutics has reported Preferred Shares for 9 years, with the latest figure at $2300.0 in Q3 2021.
- Quarterly Preferred Shares rose 91.67% year-over-year to $2300.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $2300.0 (up 91.67% YoY) and the FY2021 annual result came in at $500.0, changed N/A from the prior year.
- Preferred Shares advanced to $2300.0 in Q3 2021 per VTGN's latest filing, from $500.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $2300.0 in Q1 2018 and troughed at $500.0 in Q3 2017.
- A 5-year average of $1433.3 and a median of $1200.0 in 2017 frame the typical range for Preferred Shares.
- The sharpest annual moves came in 2018 and 2019: Preferred Shares jumped 360.0% in 2018, then sank 58.33% in 2019.
- Over 5 years, Preferred Shares stood at $500.0 in 2017, then surged by 360.0% to $2300.0 in 2018, then changed by 0.0% to $2300.0 in 2019, then changed by 0.0% to $2300.0 in 2020, then changed by 0.0% to $2300.0 in 2021.
- According to Business Quant data, Preferred Shares over the past three periods registered $2300.0, $500.0, and $500.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Vistagen Therapeutics | 10.41 Mn | 10.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2,300.00 |
| Jun 30, 2021 | 500.00 |
| Mar 31, 2021 | 500.00 |
| Dec 31, 2020 | 2,300.00 |
| Sep 30, 2020 | 1,200.00 |
| Jun 30, 2020 | 1,200.00 |
| Dec 31, 2019 | 2,300.00 |
| Sep 30, 2019 | 500.00 |
| Jun 30, 2019 | 2,300.00 |
| Mar 31, 2019 | 1,200.00 |
| Dec 31, 2018 | 2,300.00 |
| Sep 30, 2018 | 1,200.00 |
| Jun 30, 2018 | 2,300.00 |
| Mar 31, 2018 | 2,300.00 |
| Dec 31, 2017 | 500.00 |
| Sep 30, 2017 | 500.00 |
| Jun 30, 2017 | 1,200.00 |
| Mar 31, 2017 | 1,200.00 |
| Dec 31, 2016 | 500.00 |
| Mar 31, 2016 | 2,300.00 |